MetaADEDB 2.0 @ LMMD
trolamine salicylate
(UEVAMYPIMMOEFW-UHFFFAOYSA-N)
Structure
SMILES
OC(=O)c1ccccc1O.OCCN(CCO)CCO
Type(s)
Approved
Molecular Formula:
C13H21NO6
Molecular Weight:
287.309
Log P:
-0.6443
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
5
TPSA:
121.46
CAS Number(s):
2174-16-5
Synonym(s)
1.
trolamine salicylate
2.
Myoflex
3.
triethanolamine salicylate
External Link(s)
MeSHC032758
PubChem Compound69594019
25213
CHEMBLCHEMBL2107288
DrugBankDB11079
KEGGdr:D08501
Therapeutic Target DatabaseD0A5CM
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Back PainFAERS: 2US FAERS
2Drug DependenceFAERS: 2US FAERS
3ErythemaFAERS: 2US FAERS
4Expired product administeredFAERS: 2US FAERS
5Feeling abnormalFAERS: 2US FAERS
6Accidental exposure to productFAERS: 1US FAERS
7Activities of daily living impairedFAERS: 1US FAERS
8Ankle FractureFAERS: 1US FAERS
9BunionFAERS: 1US FAERS
10Burning sensationFAERS: 1US FAERS
11Cerebrovascular accidentFAERS: 1US FAERS
12Diabetes MellitusFAERS: 1US FAERS
13Extremity contractureFAERS: 1US FAERS
14Eye irritationFAERS: 1US FAERS
15FibromyalgiaFAERS: 1US FAERS
16FractureFAERS: 1US FAERS
17Incorrect drug administration durationFAERS: 1US FAERS
18InflammationFAERS: 1US FAERS
19Intentional product misuseFAERS: 1US FAERS
20Intervertebral Disc DegenerationFAERS: 1US FAERS
21LacerationFAERS: 1US FAERS
22Meniscus injuryFAERS: 1US FAERS
23Musculoskeletal PainFAERS: 1US FAERS
24Myocardial InfarctionFAERS: 1US FAERS
25Pain of skinFAERS: 1US FAERS
26PainFAERS: 1US FAERS
27Poor peripheral circulationFAERS: 1US FAERS
28PruritusFAERS: 1US FAERS
29Rotator cuff syndromeFAERS: 1US FAERS
30Therapeutic response unexpectedFAERS: 1US FAERS
31ThrombosisFAERS: 1US FAERS
32VomitingFAERS: 1US FAERS
33Walking aid userFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.